Virtu Financial’s Ensysce Biosciences ENSC Stock Holding History

Virtu Financial’s Portfolio ENSC Stock Details ENSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28K	Buy	95,391 +82,078	+617%	+$29.6K	﹤0.01%	1304
2026 Q1	$7K	Buy	+13,313	New	+$8.44K	﹤0.01%	1481
2025 Q4	–	Sell	-14,222	Closed	-$34K	–	1808
2025 Q3	$34K	Buy	+14,222	New	+$30.6K	﹤0.01%	1199
2024 Q3	–	Sell	-756	Closed	-$6K	–	1508
2024 Q2	$6K	Buy	+756	New	+$6.89K	﹤0.01%	1172
2023 Q2	–	Sell	-896	Closed	-$65K	–	1654
2023 Q1	$65K	Buy	+896	New	+$103K	0.01%	1057
2022 Q4	–	Sell	-12	Closed	-$9K	–	1758
2022 Q3	$9K	Buy	+12	New	+$19.6K	﹤0.01%	1530
2022 Q2	–	Sell	-7	Closed	-$28K	–	1707
2022 Q1	$28K	Buy	+7	New	+$46.3K	﹤0.01%	1249
2021 Q4	–	Sell	-7	Closed	-$78K	–	1844
2021 Q3	$78K	Buy	+7	New	+$137K	0.01%	1201

Other funds holding ENSC

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

TIAM2

Tru Independence Asset Management 2 Portland, Oregon $185M AUM 20.3% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Virtu Financial's ENSC Position: Q2 2026 in Review

Virtu Financial increased its Ensysce Biosciences (ENSC) stake by 617% in Q2 2026, buying an estimated $29.6K and bringing the position to 95,391 shares worth $28K. The position accounts for ﹤0.01% of the portfolio, ranked #1304.

Virtu Financial first reported a position in ENSC in Q3 2021 and has held it in 8 quarters since. The position peaked at $78K in Q3 2021. 18 funds tracked by Wall St. Rank hold ENSC as of Q2 2026.

Virtu Financial held 95,391 shares of Ensysce Biosciences worth $28K as of Q2 2026.
Virtu Financial bought 82,078 Ensysce Biosciences shares in Q2 2026, an estimated $29.6K.
Ensysce Biosciences made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1304 holding.
Virtu Financial first reported a position in Ensysce Biosciences in Q3 2021 and has held it in 8 quarters since.
Virtu Financial's Ensysce Biosciences position peaked at $78K in Q3 2021.
18 funds tracked by Wall St. Rank held Ensysce Biosciences as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.